Ismn Stada

Isosorbide mononitrate, the active ingredient in Ismn Stada, is an organic nitrate presented as an oral tablet for oral use. It is employed to prevent and treat angina pectoris in adults, helping to reduce the frequency of chest pain episodes by dilating coronary vessels and decreasing cardiac workload.

GNH USA supplies Ismn Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU quality standards and is manufactured under GMP conditions and is distributed to multiple regions.

Isosorbide mononitrate is used in the anti‑anginal drug class to manage coronary artery disease‑related chest pain.

Prophylaxis of angina pectoris: reduces the frequency of angina attacks in patients with chronic stable angina. Treatment of stable angina: improves exercise tolerance and decreases episodes of chest discomfort during physical activity. Prevention of angina attacks: maintains symptom control and reduces reliance on short‑acting nitrates.

Isosorbide mononitrate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache - Dizziness - Flushing - Nausea

Serious or Rare Side Effects: - Severe hypotension - Syncope - Allergic reactions such as rash or angioedema - Stevens‑Johnson syndrome (rare)

Careful monitoring and patient education are essential when using isosorbide mononitrate.

Monitor blood pressure: check for hypotension especially after dose initiation or dose changes. Avoid abrupt discontinuation: taper to prevent rebound angina. Use caution in hepatic impairment: metabolism may be reduced. Assess for nitrate tolerance: effectiveness may diminish with continuous use. Avoid concomitant use with phosphodiesterase‑5 inhibitors: risk of profound hypotension. Store at room temperature: keep in the original container, protect from moisture and heat.

Isosorbide mononitrate can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): may cause severe hypotension. - Other nitrates or nitroglycerin preparations: additive vasodilatory effect leading to dangerous blood pressure drop.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (ACE inhibitors, beta‑blockers, calcium channel blockers): may enhance blood pressure‑lowering effect. - Alcohol consumption: can increase hypotensive response. - Diuretics: may potentiate volume depletion and orthostatic symptoms.